Treatment of age-related macular degeneration

被引：3
作者：
Bunting, Roland [1 ]
Guymer, Robyn [1 ]
机构：
[1] Royal Victorian Eye & Ear Hosp, Melbourne, Vic, Australia
来源：
AUSTRALIAN PRESCRIBER | 2012年 / 35卷 / 03期
关键词：
anti-vascular endothelial growth factor; bevacizumab; choroidal neovascularisation; ranibizumab; RANIBIZUMAB; METAANALYSIS;
D O I：
10.18773/austprescr.2012.038
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
Age-related macular degeneration is a common cause of visual loss. There may be choroidal neovascularisation or geographic atrophy. Evidence is accumulating for the importance of avoidable risk factors in age-related macular degeneration, such as smoking and obesity. Research confirms that there is an important hereditary component to the disease. Anti-vascular endothelial growth factors have improved the outlook for patients suffering from neovascular age-related macular degeneration. Recent work has concentrated on refining the frequency and pattern of delivery of these drugs to the vitreous cavity. There are few treatment options for geographic atrophy.
引用
收藏
页码：90 / 93
页数：4
相关论文
共 9 条
[1]   Ranibizumab versus verteporfin for neovascular age-related macular degeneration [J].
Brown, David M. ;
Kaiser, Peter K. ;
Michels, Mark ;
Soubrane, Gisele ;
Heier, Jeffrey S. ;
Kim, Robert Y. ;
Sy, Judy P. ;
Schneider, Susan .
NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (14) :1432-1444
[2]   Clinical risk factors for age-related macular degeneration: a systematic review and meta-analysis [J].
Chakravarthy, Usha ;
Wong, Tien Y. ;
Fletcher, Astrid ;
Piault, Elisabeth ;
Evans, Christopher ;
Zlateva, Gergana ;
Buggage, Ronald ;
Pleil, Andreas ;
Mitchell, Paul .
BMC OPHTHALMOLOGY, 2010, 10
[3]   Dietary antioxidants and primary prevention of age related macular degeneration: systematic review and meta-analysis [J].
Chong, Elaine W-T ;
Wong, Tien Y. ;
Kreis, Andreas J. ;
Simpson, Julie A. ;
Guymer, Robyn H. .
BMJ-BRITISH MEDICAL JOURNAL, 2007, 335 (7623) :755-759
[4]   A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss - AREDS Report No. 8 [J].
Kassoff, A ;
Kassoff, J ;
Buehler, J ;
Eglow, M ;
Kaufman, F ;
Mehu, M ;
Kieval, S ;
Mairs, M ;
Graig, B ;
Quattrocchi, A ;
Jones, D ;
Locatelli, J ;
Ruby, A ;
Capone, A ;
Garretson, B ;
Hassan, T ;
Trese, MT ;
Williams, GA ;
Regan, V ;
Manatrey, P ;
Streasick, P ;
Szydlowski, L ;
McIver, F ;
Bridges, C ;
Stanley, C ;
Cumming, K ;
Lewis, B ;
Zajechowski, M ;
Margherio, RR ;
Cox, MS ;
Camille, J ;
Falk, R ;
Siedlak, P ;
Neubert, C ;
Klein, ML ;
Stout, JT ;
O'Malley, A ;
Lauer, AK ;
Robertson, JE ;
Wilson, DJ ;
Beardsley, C ;
Anderson, H ;
Wallace, P ;
Smith, G ;
Howard, S ;
Dreyer, RF ;
Ma, C ;
Chenoweth, RG ;
Zilis, JD ;
Johnson, M .
ARCHIVES OF OPHTHALMOLOGY, 2001, 119 (10) :1417-1436
[5]   Ranibizumab and Bevacizumab for Neovascular Age-Related Macular Degeneration The CATT Research Group [J].
Martin, Daniel F. ;
Maguire, Maureen G. ;
Ying, Gui-shuang ;
Grunwald, Juan E. ;
Fine, Stuart L. ;
Jaffe, Glenn J. .
NEW ENGLAND JOURNAL OF MEDICINE, 2011, 364 (20) :1897-1908
[6]  
National Eye Institute, AG REL EYE DIS STUD
[7]   C-Reactive Protein Levels and Complement Factor H Polymorphism Interaction in Age-related Macular Degeneration and Its Progression [J].
Robman, Luba ;
Baird, Paul N. ;
Dimitrov, Peter N. ;
Richardson, Andrea J. ;
Guymer, Robyn H. .
OPHTHALMOLOGY, 2010, 117 (10) :1982-1988
[8]   Ranibizumab for neovascular age-related macular degeneration [J].
Rosenfeld, Philip J. ;
Brown, David M. ;
Heier, Jeffrey S. ;
Boyer, David S. ;
Kaiser, Peter K. ;
Chung, Carol Y. ;
Kim, Robert Y. .
NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (14) :1419-1431
[9]   Levels of vascular endothelial growth factor are elevated in the vitreous of patients with subretinal neovascularisation [J].
Wells, JA ;
Murthy, R ;
Chibber, R ;
Nunn, A ;
Molinatti, PA ;
Kohner, EM ;
Gregor, ZJ .
BRITISH JOURNAL OF OPHTHALMOLOGY, 1996, 80 (04) :363-366
1